Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Abbott Labs settlement

This article was originally published in The Tan Sheet

Executive Summary

Abbott Labs settlement: Similac infant formula maker will pay $4.7 mil. to settle price-fixing claims filed last summer by the state of Minnesota, Attorney General Hubert Humphrey announced on May 24. "The suit was filed on behalf of consumers and taxpayers who support the Minnesota Women, Infants and Children (WIC) program after it was discovered that the price of infant formula had increased by 130% between 1980 and 1993, while the price of milk had decreased by 6% during that period," Humphrey explained. Enfamil manufacturer Mead Johnson also was charged in the suit but has not settled; Humphrey predicts the suit may go to trial this fall. The Minnesota settlement is only a fraction of the $32.5 mil. in compensation that Abbott reportedly has agreed to pay to settle price-fixing suits in 17 states...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS085438

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel